BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18076920)

  • 1. Differences in organ system of distant metastasis by renal cell carcinoma subtype.
    Hoffmann NE; Gillett MD; Cheville JC; Lohse CM; Leibovich BC; Blute ML
    J Urol; 2008 Feb; 179(2):474-7. PubMed ID: 18076920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second primary malignancies associated with renal cell carcinoma histological subtypes.
    Thompson RH; Leibovich BC; Cheville JC; Webster WS; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Sep; 176(3):900-3; discussion 903-4. PubMed ID: 16890648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
    Leibovich BC; Lohse CM; Crispen PL; Boorjian SA; Thompson RH; Blute ML; Cheville JC
    J Urol; 2010 Apr; 183(4):1309-15. PubMed ID: 20171681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solitary liver metastasis of chromophobe renal cell carcinoma 20 years after nephrectomy treated by hepatic resection.
    Lordan JT; Fawcett WJ; Karanjia ND
    Urology; 2008 Jul; 72(1):230.e5-6. PubMed ID: 18329075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous nephrectomy and right hepatectomy for metastatic chromophobe renal cell carcinoma: report of a case and review of the literature.
    Talarico F; Buli P; Iusco D; Sangiorgi A; Jovine E
    Chir Ital; 2007; 59(2):257-61. PubMed ID: 17500184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
    Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
    BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromophobe renal cell carcinoma: a clinicopathological study of 16 cases].
    Nakaigawa N; Yao M; Kondo K; Kishida T; Noguchi K; Kubota Y; Nagashima Y; Kawano N; Inayama Y; Nozawa A
    Hinyokika Kiyo; 2006 Jan; 52(1):1-6. PubMed ID: 16479980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
    Lughezzani G; Jeldres C; Isbarn H; Perrotte P; Shariat SF; Sun M; Widmer H; Arjane P; Peloquin F; Pharand D; Patard JJ; Graefen M; Montorsi F; Karakiewicz PI
    J Urol; 2009 Oct; 182(4):1287-93. PubMed ID: 19683281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features on chromophobe renal cell carcinoma].
    Wang ZH; DU LH; Hu ZQ; Chen XG; Zhao X; Wang SG; Zhuang QY; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2011 Apr; 49(4):320-3. PubMed ID: 21612697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
    Assouad J; Banu E; Brian E; Pham DN; Dujon A; Foucault C; Riquet M
    Eur J Cardiothorac Surg; 2008 May; 33(5):794-8. PubMed ID: 18304831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous adrenalectomy during radical nephrectomy for renal cell carcinoma will not cure patients with adrenal metastasis.
    von Knobloch R; Schrader AJ; Walthers EM; Hofmann R
    Urology; 2009 Feb; 73(2):333-6. PubMed ID: 19038420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
    Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
    Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of bone metastases from renal cell carcinoma].
    Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
    Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.